Build status - In Progress

Evaluating the Effect of Sage-718 on Cognitive Function in Participants with Huntington’s Disease

Enrolling By Invitation
25 years - 65 years
All
4 participants needed
1 Location

Brief description of study

This is a study that evaluates SAGE-718 in participants with Huntington's Disease.

Detailed description of study

This is a study that evaluates SAGE-718 in participants with Huntington's Disease.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research, Huntington’s
  • Age: 25 years - 65 years
  • Gender: All

Age 25 to 65 Huntington's Disease

Updated on 04 Aug 2024. Study ID: 851128
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research